- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Bliss GVS Pharma Limited — Important, 28-05-2026: Updates
28-05-2026 | 04:48 pm
28-05-2026 | 04:48 pm
Bliss GVS Pharma incurred fines of ₹66,000 each from BSE & NSE for delays in obtaining shareholder approval for an independent director's appointment. The company previously had disclosure delays but reports strengthened internal processes for future compliance.
No comments yet. Be the first to comment!